Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer

NCT01105377 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

NIH

Sponsor class

Conditions

Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IV Colon Cancer
Stage IV Rectal Cancer

Interventions

DRUG: entinostat
DRUG: azacitidine
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)